Sino Biopharm climbs most in five weeks on cancer drug development progress

Sino Biopharmaceutical

09/02/2026 06:11

** Shares of Sino Biopharmaceutical 1177.HK climb 3.7% to HK$6.72, on course for the biggest one-day pct rise since January 7

** Stock hits highest since January 30 on its fifth straight session of gain

** Company said its unit's drug has completed patient enrollment in its Phase III registrational clinical trial for treatment of metastatic gastric and gastroesophageal junction adenocarcinoma

** YTD, stock up 7.6%, Hang Seng Biotech Index .HSBIO up 9.4%

(Reporting by Donny Kwok)

((donny.kwok@thomsonreuters.com))